THE RISK OF LATE BREAST CANCER SCREENING VERSUS AXILLARY LYMPHADENOPATHY ASSOCIATED WITH COVID-19 VACCINATION (Atena Editora)

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributor.authorrecommendations, The coronavirus ANA CAROLINA MORAES GOMES DE SOUZAdisease 2019 (COVID-19) pandemic has significantly impacted morbidity and mortality worldwide. Unilateral axillary lymphadenopathy induced by the COVID-19 vaccine is particularly relevant in women with breast cancer, with a predilection for metastasis to the axillary lymph nodes. Clinicians, radiologists, and patients may be concerned about COVID-19 vaccine-induced unilateral axillary lymphadenopathy because it may be a sign of breast cancer metastasis, leading to a diagnostic conundrum over whether to recommend a biopsy or short-term follow-up. This literature review aims to assess the best available evidence of axillary lymphadenopathy after COVID-19 vaccination. Recognizing COVID-19 vaccine-induced unilateral axillary lymphadenopathy as a potential differential diagnosis and making efforts to investigate the patient's vaccination history are crucial to avoid overestimating the burden of axillary disease and making appropriate therapeutic .-
Autor(es): dc.contributor.authorNOSE, ANDRE LUIS YAMAMOTO-
Autor(es): dc.contributor.authorLOPES, PATRICK DE ABREU CUNHA-
Data de aceite: dc.date.accessioned2022-05-09T16:55:10Z-
Data de disponibilização: dc.date.available2022-05-09T16:55:10Z-
Data de envio: dc.date.issued2022-04-18-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/701822-
Resumo: dc.description.abstractThe coronavirus disease 2019 (COVID-19) pandemic has significantly impacted morbidity and mortality worldwide. Unilateral axillary lymphadenopathy induced by the COVID-19 vaccine is particularly relevant in women with breast cancer, with a predilection for metastasis to the axillary lymph nodes. Clinicians, radiologists, and patients may be concerned about COVID-19 vaccine-induced unilateral axillary lymphadenopathy because it may be a sign of breast cancer metastasis, leading to a diagnostic conundrum over whether to recommend a biopsy or short-term follow-up. This literature review aims to assess the best available evidence of axillary lymphadenopathy after COVID-19 vaccination. Recognizing COVID-19 vaccine-induced unilateral axillary lymphadenopathy as a potential differential diagnosis and making efforts to investigate the patient's vaccination history are crucial to avoid overestimating the burden of axillary disease and making appropriate therapeutic recommendations.pt_BR
Idioma: dc.language.isopt_BRpt_BR
Palavras-chave: dc.subjectVACCINApt_BR
Título: dc.titleTHE RISK OF LATE BREAST CANCER SCREENING VERSUS AXILLARY LYMPHADENOPATHY ASSOCIATED WITH COVID-19 VACCINATION (Atena Editora)pt_BR
Tipo de arquivo: dc.typelivro digitalpt_BR
Aparece nas coleções:Livros digitais

Arquivos associados:
THE RISK.pdf180,33 kBAdobe PDF/bitstream/capes/701822/1/THE RISK.pdfDownload